Theratechnologies Inc. (THTX)

Theratechnologies Income Statement

Financials in millions CAD. Fiscal year is December - November.

Year Ending	TTM	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020	Nov 30, 2019
Revenue	82.57	81.76	80.06	69.82	66.05	63.22
Revenue Growth (YoY)	3.62%	2.13%	14.66%	5.71%	4.49%	39.81%
Cost of Revenue	19.86	19.64	23.84	18.38	22.02	21.19
Gross Profit	62.71	62.13	56.22	51.45	44.03	42.02
Selling, General & Admin	39.84	42.39	56.75	43.53	39.09	34.81
Research & Development	19.1	30.37	36.94	28.27	18.02	10.84
Other Operating Expenses	0	0	2.44	4.88	4.88	4.88
Operating Expenses	58.94	72.76	96.13	76.68	61.99	50.54
Operating Income	3.77	-10.63	-39.91	-25.24	-17.96	-8.51
Interest Expense / Income	12.98	15.06	7.56	6.62	5.41	5.08
Other Expense / Income	-2.65	-2.15	-0.67	-0.2	-0.72	-1.1
Pretax Income	-6.57	-23.54	-46.79	-31.66	-22.65	-12.5
Income Tax	0.43	0.42	0.44	0.06	0.02	0
Net Income	-7	-23.96	-47.24	-31.73	-22.67	-12.5
Shares Outstanding (Basic)	46	24	24	24	19	15
Shares Change	89.99%	1.75%	0.03%	23.59%	26.13%	-
EPS (Basic)	-0.14	-0.91	-1.98	-1.37	-1.16	-0.64
EPS (Diluted)	-0.14	-0.91	-1.98	-1.37	-1.16	-0.64
Free Cash Flow	-0.79	-6	-15.68	-17.63	-13.59	-4.61
Free Cash Flow Per Share	-0.02	-0.25	-0.66	-0.74	-0.71	-0.30
Gross Margin	75.94%	75.99%	70.22%	73.68%	66.66%	66.48%
Operating Margin	4.56%	-13.00%	-49.85%	-36.14%	-27.19%	-13.47%
Profit Margin	-8.47%	-29.30%	-59.00%	-45.44%	-34.32%	-19.77%
Free Cash Flow Margin	-0.96%	-7.33%	-19.58%	-25.25%	-20.57%	-7.29%
EBITDA	9.64	-5.17	-26.76	-16.29	-8.72	0.08
EBITDA Margin	11.67%	-6.32%	-33.43%	-23.33%	-13.20%	0.12%
Depreciation & Amortization	3.22	3.32	12.47	8.75	8.52	7.5
EBIT	6.42	-8.48	-39.24	-25.04	-17.24	-7.42
EBIT Margin	7.77%	-10.37%	-49.01%	-35.86%	-26.10%	-11.73%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).